(Q39254311)

10 September 2017

title

Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome (English)

1 reference

10 September 2017

Hong Wang

1

1 reference

10 September 2017

Rong Fan

2

1 reference

10 September 2017

Xiao-Qin Wang

3

1 reference

10 September 2017

De-Pei Wu

4

1 reference

10 September 2017

Guo-Wei Lin

5

1 reference

10 September 2017

Yang Xu

6

1 reference

10 September 2017

Wei-Yang Li

7

1 reference

10 September 2017

publication date

24 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

92

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

199-209

1 reference

Wnt signaling: a common theme in animal development

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt signaling through canonical and non-canonical pathways: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

WNT signalling and haematopoiesis: a WNT-WNT situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt signaling in the intestinal epithelium: from endoderm to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt/Frizzled signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Secreted antagonists of the Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

A role for Wnt signalling in self-renewal of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt proteins are lipid-modified and can act as stem cell growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

RACK1 regulates G1/S progression by suppressing Src kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Wnt signalling in mammalian development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

SARPs: a family of secreted apoptosis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1595-Y

10.1007/S00277-012-1595-Y

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference